Natera, Inc. Common Stock vs. Exagen Inc. Common Stock
Natera, Inc. Common Stock and Exagen Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| NTRA | XGN | |
|---|---|---|
| Market Cap | $53.25 billion | $203.74 million |
| Revenue (TTM) | — | $71.12 million |
| Net Income (TTM) | — | $-18,923,000 |
NTRA leads on 1 of 1 size & scale factors.
Valuation
| NTRA | XGN | |
|---|---|---|
| Price / Book | — | 16.68 |
| Price / Sales | — | 2.86 |
NTRA and XGN split the valuation factors evenly.
Profitability
| NTRA | XGN | |
|---|---|---|
| Net Margin | — | -26.61% |
| Return on Equity | — | -154.90% |
NTRA and XGN split the profitability factors evenly.
Risk & Sentiment
| NTRA | XGN | |
|---|---|---|
| Short Interest | 0.96% | 0.02% |
XGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: NTRA overview, NTRA financials, XGN overview, XGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.